ADSTILADRIN Early Utilization and Outcomes in the Real World Setting is a study to understand how ADSTILADRIN, a treatment, is being used in the US and Israel. Participants in this study will not receive any experimental treatment. Instead, researchers will collect data from real patients who are already using ADSTILADRIN as part of their regular treatment plan. To join, you need to have been prescribed ADSTILADRIN by your doctor after September 5, 2023, be 18 years or older, and sign a consent form. You cannot join if you are in another clinical trial, have used ADSTILADRIN in a different trial, or are pregnant or breastfeeding. This study is important because it helps doctors understand how treatments work in everyday life.

• This is a non-interventional study, meaning you won’t try anything new.
• You must be at least 18 years old and not in other clinical trials to participate.
• The study will collect data but not provide any additional treatment.